Readiness to Implement Symptom Management Care Pathways in Pediatric Cancer

L Lee Dupuis, Allison Grimes, Emily Vettese, Lisa M Klesges, Lillian Sung, L Lee Dupuis, Allison Grimes, Emily Vettese, Lisa M Klesges, Lillian Sung

Abstract

Background: To describe barriers to pediatric cancer symptom management care pathway implementation and the impact of the COVID-19 pandemic on clinical research evaluating their implementation. Methods: We included 25 pediatric oncology hospitals in the United States that supported a grant submission to perform a cluster randomized trial in which the intervention encompassed care pathways for symptom management. A survey was distributed to site principal investigators to measure contextual elements related to care pathway implementation. Questions included the inner setting measures of the Consolidated Framework for Implementation Research (CFIR), study-specific potential barriers and the impact of the COVID-19 pandemic on clinical research. The Wilcoxon rank sum test was used to compare characteristics of institutions that agreed that their department supported the implementation of symptom management care pathways vs. institutions that did not agree. Results: Of the 25 sites, one withdrew because of resource constraints and one did not respond, leaving 23 institutions. Among the seven CFIR constructs, the least supported was implementation climate; 57% agreed there was support, 39% agreed there was recognition and 39% agreed there was prioritization for symptom management care pathway implementation at their institution. Most common barriers were lack of person-time to create care pathways and champion their use (35%), lack of interest from physicians (30%) and lack of information technology resources (26%). Most sites reported no negative impact of the COVID-19 pandemic across research activities. Sites with fewer pediatric cancer patients were more likely to agree that staff are supported to implement symptom management care pathways (P=0.003). Conclusions: The most commonly reported barriers to implementation were lack of support, recognition and prioritization. The COVID-19 pandemic was not a major barrier to clinical research activities in pediatric oncology. Clinical Trial Registration: NCT04614662.

Conflict of interest statement

Competing interests: The authors declare that they have no competing financial interests.

References

    1. Dupuis LL, Johnston DL, Baggott C, Hyslop S, Tomlinson D, Gibson P et al. Validation of the Symptom Screening in Pediatrics Tool in Children Receiving Cancer Treatments. J Natl Cancer Inst. 2018;110(6):661–8.
    1. Hyslop S, Davis H, Duong N, Loves R, Schechter T, Tomlinson D, et al. Symptom documentation and intervention provision for symptom control in children receiving cancer treatments. Eur J Cancer. 2019;109:120–8.
    1. Sung L. Priorities for quality care in pediatric oncology supportive care. J Oncol Pract. 2015;11 (3):187–9.
    1. Dupuis LL, Cook S, Robinson PD, Tomlinson D, Vettese E, Sung L. Optimizing symptom control in children and adolescents with cancer. Pediatr Res. 2019;86(5):573–8.
    1. Tomlinson D, Dupuis LL, Gibson P Johnston DL, Portwine C, Baggott C, et al. Initial development of the Symptom Screening in Pediatrics Tool (SSPedi). Support Care Cancer. 2014;22(1):71–5.
    1. O’Sullivan C, Dupuis LL, Gibson P Johnston DL, Baggott C, Portwine C, et al. Refinement of the symptom screening in pediatrics tool (SSPedi). Br J Cancer. 2014;111(7):1262–8.
    1. O’Sullivan C, Lee Dupuis L, Gibson P Johnston DL, Baggott C, Portwine C, et al. Evaluation of the electronic self-report Symptom Screening in Pediatrics Tool (SSPedi). BMJ Support Palliat Care. 2018;8(1):110–6.
    1. Cook S, Vettese E, Tomlinson GA, Soman D, Schechter T, Kuczynski S, et al. Feasibility of a randomized controlled trial of symptom screening and feedback to healthcare providers compared with standard of care using the SPARK platform. Support Care Cancer. 2020;28(6):2729–34.
    1. Vettese E, Cook S, Soman D, Kuczynski S, Spiegler B, Davis H, et al. Longitudinal evaluation of Supportive care Prioritization, Assessment and Recommendations for Kids (SPARK), a symptom screening and management application. BMC Cancer. 2019;19(1):458.
    1. Cook S, Vettese E, Soman D, Hyslop S, Kuczynski S, Spiegler B, et al. Initial development of Supportive care Assessment, Prioritization and Recommendations for Kids (SPARK), a symptom screening and management application. BMC Med Inform Decis Mak. 2019;19(1) :9.
    1. Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. SARS-CoV-2 Infection in Children. N Engl J Med. 2020;382(17):1663–5.
    1. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.
    1. Clinical Practice Guidelines. Directions for a New Program, Institute of Medicine. Washington, DC: National Academy Press; 1990.
    1. Clinical Practice Guidelines We Can Trust. Washington, D.C.: Institute of Medicine, National Academies Press; 2011.
    1. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6.
    1. Campbell H, Hotchkiss R, Bradshaw N, Porteous M. Integrated care pathways. BMJ. 1998;316(7125):133–7.
    1. Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.
    1. Fernandez ME, Walker TJ, Weiner BJ, Calo WA, Liang S, Risendal B, et al. Developing measures to assess constructs from the Inner Setting domain of the Consolidated Framework for Implementation Research. Implement Sci. 2018;13:52.
    1. Stokes T, Tumilty E, Doolan-Noble F, Gauld R. HealthPathways implementation in a New Zealand health region: a qualitative study using the Consolidated Framework for Implementation Research. BMJ Open. 2018;8(12):e025094.
    1. Robey N, Margolies S, Sutherland L, Rupp C, Black C, Hill T, et al. Understanding staff- and system-level contextual factors relevant to trauma-informed care implementation. Psychol Trauma [Internet]. 2020. Available from: .
    1. Sathian B, Asim M, Banerjee I, Pizarro AB, Roy B, van Teijlingen ER, et al. Impact of COVID-19 on clinical trials and clinical research: A systematic review. Nepal J Epidemiol. 2020;10(3):878–87.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir